A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Neurogene Inc.
- Study ID
- NCT05898620
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 3 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- NGN-401 — GENETICNGN-401 is a non-replicating, recombinant AAV9 carrying a full length human MECP2 transgene.
Study Details
This study will evaluate the efficacy and safety profiles of the investigational gene therapy, NGN-401, in females with typical Rett syndrome.
Key Dates
- Start date
- Jun 13, 2023
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 33 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Pediatric 1e15 vg dose (fully enrolled)Dose Level 1 for ages 4-10 years
- Experimental: Adolescent/Adult 1e15 vg Dose (fully enrolled)Dose Level 1 for ages 11 years \& above
- Experimental: Pediatric 3e15 vg dose (discontinued)Dose Level 2 for ages 4-10 years (discontinued)
- Experimental: Pivotal CohortDose Level 1 for ages 3 and above
Primary Outcome Measure
Efficacy of NGN-401 [ Time Frame: 52 Weeks ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | - |
| UCSF Benioff Children's Hospital Oakland | Oakland | California | 94609 | - |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | - |
| Nicklaus Children's Hospital Research Institute | Miami | Florida | 33155 | - |
| Rush University Medical Center | Chicago | Illinois | 60612 | - |
| Kennedy Krieger Institute | Baltimore | Maryland | 21205 | - |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | - |
| Montefiore Medical Center | New York | New York | 10467 | - |
| UNC at Chapel Hill | Chapel Hill | North Carolina | 27514 | - |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | - |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | - |
| Texas Children's Hospital | Houston | Texas | 77030 | - |
Find similar trials in Birmingham, AL
By research site
Related Studies
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- Parent and Infant Inter(X)Action Intervention (PIXI)Enrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- Rett Syndrome RegistryRecruiting · International Rett Syndrome Foundation · Birmingham, Alabama
- A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)PHASE3 · Recruiting · Taysha Gene Therapies, Inc. · La Jolla, California